Benzinga | Dec 15, 2021 07:03AM EST

Citigroup Upgrades Edwards Lifesciences to Buy, Raises Price Target to $142

Citigroup analyst Joanne Wuensch upgrades Edwards Lifesciences (NYSE:EW) from Neutral to Buy and raises the price target from $120 to $142.